rAAV8 vector expressing DX88-HSA fusion protein (NGGT Biotechnology)

N/A

Report date: 2025/06/11 10:49:21

Base Information

Drug NamerAAV8 vector expressing DX88-HSA fusion protein (NGGT Biotechnology)
Drug Alias NameAAV8 DX88-HAS
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAngioedemas, Hereditary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSuzhou Nuojiebei Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Nuojiebei Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsAngioedemas, Hereditary
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A